Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 13 citing Pan: Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models.... (0.07 sec) 

[PDF] Animal model in type 2 diabetes research: An overview


K Srinivasan, P Ramarao - Indian Journal of Medical Research, 2007 - icmr.nic.in
Type 2 diabetes is a complex and heterogeneous disorder presently affecting more
than 100 million people worldwide and causing serious socio-economic problems.
Appropriate experimental models are essential tools for understanding the ...
Cited by 25 - Related articles - View as HTML - BL Direct - All 3 versions

Inheritance patterns of transcript levels in F1 hybrid mice

- genetics.org
X Cui, J Affourtit, KR Shockley, Y Woo, GA … - Genetics, 2006 - Genetics Soc America
Genetic analysis of transcriptional regulation is a rapidly emerging field of
investigation that promises to shed light on the regulatory networks that
control gene expression. Although a number of such studies have been ...
Cited by 15 - Related articles - BL Direct - All 8 versions

Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 …

- endojournals.org
EH Leiter, PC Reifsnyder, W Zhang, H Pan, Q … - Endocrinology, 2006 - Endocrine Soc
Polygenic mouse models for obesity-induced type 2 diabetes (T2D) more accurately
reflect the most common manifestations of the human disease. Two inbred mouse
strains (NON/Lt and NZO/HlLt) separately contributed T2D susceptibility- ...
Cited by 14 - Related articles - BL Direct - All 5 versions

A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first …

- jbc.org
RB Sher, C Aoyama, KA Huebsch, S Ji, J … - Journal of Biological Chemistry, 2006 - ASBMB
Muscular dystrophies include a diverse group of genetically heterogeneous
disorders that together affect 1 in 2000 births worldwide. The diseases are
characterized by progressive muscle weakness and wasting that lead to ...
Cited by 13 - Related articles - BL Direct - All 5 versions

Hepatic phosphatidylethanolamine N-methyltransferase expression is increased in diabetic …

- nutrition.org
CS Hartz, KM Nieman, RL Jacobs, DE Vance, … - Journal of Nutrition, 2006 - Am Soc Nutrition
Phosphatidylcholine is an essential phospholipid that is synthesized by 2
different pathways, the CDP-choline pathway and the methylation of
phosphatidylethanolamine by phosphatidylethanolamine N-methyltransferase ...
Cited by 8 - Related articles - BL Direct - All 5 versions

Rosiglitazone: possible complications and treatment of non-alcoholic steatohepatitis (NASH)

- theclinics.com
JH Henriksen, H Ring-Larsen - Journal of Hepatology, 2008 - Elsevier
We conducted an unplanned interim analysis of a randomized, multicenter,
open-label, noninferiority trial involving 4447 patients with type 2 diabetes
who had inadequate glycemic control while receiving metformin or ...
Cited by 8 - Related articles - All 15 versions

Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal …

- jbc.org
DE Vance, Z Li, RL Jacobs - Journal of Biological Chemistry, 2007 - ASBMB
In 1961, when Bremer and Greenberg (1) characterized the methylation reactions
that convert phosphatidylethanolamine (PE) 4 to phosphatidylcholine (PC), it is
unlikely that they would have predicted the physiological impact of this ...
Cited by 7 - Related articles - All 4 versions

Pharmacogenomics of metabolic effects of rosiglitazone


O Šeda, L Šedová, O Oliyarnyk, L Kazdová, … - Pharmacogenomics, 2008 - Future Medicine
* These authors contributed equally to this work. ... Introduction:
Thiazolidinediones are increasingly used drugs for the treatment of Type 2
diabetes. The individual response to thiazolidinedione therapy, ranging ...
Cited by 3 - Related articles - BL Direct - All 4 versions

A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine …

- nih.gov
HJ Pan, DS Agate, BL King, MK Wu, SL … - FEBS letters, 2006 - Elsevier
New Zealand obese (NZO/HlLt) male mice develop polygenic diabetes and altered
phosphatidylcholine metabolism. The gene encoding phosphatidylcholine transfer
protein (PC-TP) is sited within the support interval for Nidd3, a recessive ...
Cited by 3 - Related articles - All 12 versions

6 The New Zealand Obese Mouse: Polygenic Model of Obesity, Glucose Intolerance, and …


BC Fam, S Andrikopoulos - Animal models of diabetes: frontiers in research, 2007 - books.google.com
6 The New Zealand Obese Mouse: Polygenic Model of Obesity, Glucose Intolerance,
and the Metabolic Syndrome Barbara C. Fam and Sofianos Andrikopoulos CONTENTS
Background 140 Obesity and Metabolic Characteristics of the NZO Mouse 141 ...
Cited by 3 - Related articles


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google